Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179785 · ClinicalTrials.gov registry record · NA
Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolar Disorder
A NA study, sponsored by Mary Phillips, MD MD (Cantab).
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT05179785: Completed NA study, sponsored by Mary Phillips, MD MD (Cantab).
NCT05179785 is a NA study that has completed, run by Mary Phillips, MD MD (Cantab). The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05179785, a NA study, has completed, sponsored by Mary Phillips, MD MD (Cantab).
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators will conduct a proof of concept study that will examine the effect of electroencephalography (EEG)-guided theta burst stimulation (TBS) on reducing mania/hypomania-related affect and reward driven behavior in adults with BD. The investigators hypothesize that TBS will reduce mania/hypomania-related affect and reward driven behavior in adults with BD.
Primary Outcome
The difference in brain activity (Beta power) in left vLPFC from pre TBS to post TBS. Higher numbers indicate more brain activity after TBS, while lower numbers indicate less brain activity (Beta power) after TBS.
Interventions
- DEVICE Intermittent Theta Burst Stimulation (iTBS)
- DEVICE Continuous Theta Burst Stimulation (cTBS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-03-23 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
What the finished NCT05179785 record still lists
NCT05179785 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Intermittent Theta Burst Stimulation (iTBS) is the first listed.
NCT05179785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05179785 about?
NCT05179785 is a clinical study titled "Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolar Disorder". Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators will conduct a proof of concept study that will examine the effect of electroencephalography (EEG)-guided theta burst stimulation ...
What is the current status of trial NCT05179785?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-03-23. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05179785?
The interventions under investigation include: Intermittent Theta Burst Stimulation (iTBS) (DEVICE), Continuous Theta Burst Stimulation (cTBS) (DEVICE).
Who is sponsoring clinical trial NCT05179785?
This trial is sponsored by Mary Phillips, MD MD (Cantab), which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05179785's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI